Transient benefit of amantadine in Parkinson's disease: the facts about the myth.
Factor
S A
SA
Department of Neurology, Albany Medical College, New York, USA.
Molho
E S
ES
D000547:Amantadine / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D016896:Treatment Outcome
D000998:Antiviral Agents; D000547:Amantadine